Youngbo Chem (014440) fair value: what the stock is really worth
As of Nov 9, 2026: fair value (intrinsic value) of Youngbo Chem stock KRW 4,401, price KRW 4,660, that is 5.5% below the price, quality 59 out of 100. Rating: fairly valued. Calculated from audited financials with 24 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 5, 2026.
How to read this chart
60‑month range 2,615 KRW – 5,441 KRW · fair‑value band 3,916 KRW – 5,503 KRW · the 4,660 KRW price screens above the 4,401 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 5, 2026.
Follow Youngbo Chem in your weekly email
Every Wednesday you see whether Youngbo Chem is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Youngbo Chemical Co., Ltd. manufactures and sells cross-linked polyolefin foam in Korea and internationally. The company offers artilon, epilon, filmy, and youngboard polyolefin foam products.
Show moreShow less
Its products are used in various applications, including automotive Material Parts, including instrumental panels, bumper protector, door trim, head liner, foam duct, PP board, pillar trim, evaporator insulation, sun visor, water shield, PE pad, and console armrest cover; Electronic Material Parts, such as mobile tap, TV and monitor sealing, panel protection sheet, packaging semiconductor components, metal plating sealing shielding, solar module sealing and fixing tape, pipe insulation, and home appliances molded products; and other industry products comprises insulation, packing supplies, packaging cushioning material, automative emblem guide, sports goods water play equipment, sports goods protector, sports goods cold weather supplies, mats, household goods, footwear, industrial tape, and medical accessary tape.
The company was founded in 1979 and is headquartered in Chungju-si, South Korea.
Stock analysis
Youngbo Chem (014440) currently trades at 4,660 KRW, while our model-based Fair Value estimate is 4,401 KRW, so the stock looks roughly fairly valued today (gap 5.9%).
Show more
Valuation
Bull case: the Multiples group reads highest at a median of 11,813 KRW per share, and 18 of the 24 models we run sit above the 4,660 KRW price.
Bear case: the Dividend Discount group reads lowest at 2,929 KRW, and 6 of the 24 models stay below the price. Data coverage for this calculation is high.
Scenario range: 3,916 KRW (bear) to 5,503 KRW (bull), the price of 4,660 KRW sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 59/100 (solid quality), in the Basic Materials sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Youngbo Chem reported revenue of 120B KRW in FY2025 versus 99.7B KRW in FY2021, a compound +4.8%/yr. Reported net income was 16.8B KRW in FY2025, compounding +48.1%/yr from FY2021.
Key figures
Market cap 90.9B KRW (≈ $67.2M) Micro · P/E ratio 4.9 · P/S ratio 0.73 · EPS (TTM) 938.01 KRW · Dividend yield 7.5% · Net margin 14.6% · Return on equity 9.7% · Return on assets (EBIT) 5.7% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 56 out of 100 (low confidence).
What moves the price
The share trades about 7% below its 52-week high and 12% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at −25% fair-value upside, at −6%, 014440 screens cheaper than that median.
Fair Value models
Bear3,916 KRWFair Value 4,401 KRWBull5,503 KRW
Price 4,660 KRW · Downside -5.5%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (504.24 KRW per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF3,376 KRW4,236 KRW5,675 KRW82
Growth DCF3,464 KRW4,276 KRW5,531 KRW80
Owner Earnings3,312 KRW4,154 KRW5,563 KRW78
All 24 models by family
DCF Models
FCF DCF3,376 KRW4,236 KRW5,675 KRW82
Owner Earnings3,312 KRW4,154 KRW5,563 KRW78
5Y Revenue Exit4,928 KRW7,369 KRW10,940 KRW72
5Y EBITDA Exit6,764 KRW10,531 KRW15,542 KRW75
5Y P/E Exit6,840 KRW10,661 KRW15,233 KRW70
10Y Revenue Exit4,061 KRW5,686 KRW7,467 KRW67
10Y EBITDA Exit5,188 KRW7,439 KRW9,899 KRW69
10Y P/E Exit5,229 KRW7,511 KRW9,736 KRW64
Earnings-Based
Graham-Dodd5,869 KRW7,561 KRW8,637 KRW67
EPV7,045 KRW7,918 KRW8,637 KRW74
Dividend Discount
Gordon GGM2,592 KRW2,783 KRW3,066 KRW69
DDM Multi-Stage2,592 KRW3,074 KRW3,668 KRW67
Multiples
P/E Multiple11,004 KRW14,672 KRW18,340 KRW63
P/S Multiple6,929 KRW9,239 KRW11,549 KRW58
P/B Multiple3,612 KRW4,817 KRW6,021 KRW55
EV/EBIT10,656 KRW14,118 KRW17,580 KRW66
EV/EBITDA11,112 KRW14,727 KRW18,341 KRW67
EV/Revenue6,737 KRW9,509 KRW12,281 KRW54
Asset-Based
NCAV (Graham)2,925 KRW4,432 KRW5,540 KRW54
Growth DCF
Growth DCF3,464 KRW4,276 KRW5,531 KRW80
Rev-Margin DCF4,928 KRW7,453 KRW10,526 KRW72
Economic Profit
Residual Income7,855 KRW8,375 KRW9,181 KRW76
ROIC Compounder7,045 KRW7,918 KRW8,637 KRW72
Growth Earnings
Growth-Adj P/E7,839 KRW11,199 KRW14,559 KRW67
The fair value above starts from this blend and is adjusted for a cyclical peak year.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.45/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+2.2%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+13.1%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+2.3%
Start year 2020 (pandemic). Over 10 years: −2.7% a year
Revenue growth 18 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+1.3%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in KRW (mathematically smoothed) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Smoothed = median of all growth paths between the years of the window (trend line on the logarithm of earnings per share): a single extreme year cannot distort the rate. The reported figure stays in the tooltip. Measured in KRW: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
≈ +55.6%
Earnings growth per share plus dividend.
Earnings per share, growth per year≈ +48.1%
Dividend (yield on the price)7.5%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.base effect: 36.9% / 4.4%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.4% → 16%
2025 sits 152% above its own trend. The rate follows the median trend of the last 5 years, not that single year.
⚠ Revenue per share shrinking 4.1%/yr over ~7Y (margins intact) ⓘStructural-decline marker: revenue PER SHARE has fallen over the last decade (robust median trend, not a single year). Backtested across 2005 to 2017, such businesses trailed the market by about 2.5 percentage points per year. Display only: it does not change the fair value or the quality score.
⚠ Base effect: the rate starts in the earnings trough around 2020 (starting value 180 per share, median 559 in 2016 to 2018). It measures the recovery from the trough, not lasting growth.
Growth Forecast
Price in line with expectations
The price assumes about as much growth as the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+3.1%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (South Korea: IMF forecast 2.1% a year to 2030, 2.1% from 2016 to 2025) that is about +1.0% a year for the price.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Chemicals · 340 stocks
Beats the industry median on 13/14 measures
Overall it ranks above its industry peers.
Valuation
Quality Score59 · Above median
Fair Value upside−5.5% · Above median
Profitability
Return on equity (12 months)9.7% · Above median
Return on assets8.0% · Top 25%
Net margin (12 months)14.6% · Top 25%
Operating margin (12 months)15.9% · Top 25%
Growth and dividend
Revenue growth (quarter YoY)11.4% · Below median
Dividend yield (12 months)7.5% · Top 25%
Balance sheet
Debt / equity0.01× · Lowest 25%
Valuation Multiplesvs Chemicals median · lower = cheaper
P/E (12 months)4.9× · Cheapest 25%
P/B0.48× · Cheapest 25%
P/S (12 months)0.73× · Cheaper than median
Price / free cash flow (fiscal year)11.6× · Cheaper than median
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Youngbo Chem Fair Value". https://www.fairvalue-calculator.com/stock/014440
Frequently asked questions
Is Youngbo Chem (014440) overvalued or undervalued?
As of Nov 5, 2026, our model estimates a fair value of 4,401 KRW versus a price of 4,660 KRW, about 6% lower (fairly valued).
What is the fair value of 014440?
Our model-based fair value for Youngbo Chem is 4,401 KRW (as of Nov 5, 2026), built from audited fundamentals. The current price: 4,660 KRW.
What is the quality score of 014440?
Youngbo Chem has a Quality Score of 59/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Youngbo Chem (014440)?
Our model-based price target is the fair value of 4,401 KRW (as of Nov 5, 2026) from 24 valuation models. Cautious scenario 3,916 KRW, optimistic scenario 5,503 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the Youngbo Chem stock forecast for 2026?
Our models put fair value at 4,401 KRW, about 6% lower versus a price of 4,660 KRW (fairly valued). Cautious scenario 3,916 KRW, optimistic scenario 5,503 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of Youngbo Chem (014440)?
Youngbo Chem reported trailing-twelve-month revenue of about 125B KRW (latest available figure, as of Nov 5, 2026).
Does Youngbo Chem pay a dividend?
Youngbo Chem currently shows a dividend yield of 7.51% relative to its recent price (as of Nov 5, 2026).
How much is the dividend of Youngbo Chem (014440) and when is the ex-dividend date?
Youngbo Chem pays a dividend of 350.00 KRW per share a year, a dividend yield of 7.5%. The last ex-dividend date was Dec 29, 2025. A dividend has been paid every year since at least 1999. The payout ratio is 37.3% of earnings. Free cash flow covers the dividend 1.14 times. Our assessment: Well covered. A low payout and the dividend is fully funded by free cash flow, a comfortable, sustainable dividend.
What growth is priced into Youngbo Chem (014440)?
For today's price to be fair in a discounted-cash-flow model, Youngbo Chem would have to grow free cash flow by +3.1 % per year for five years (discount rate 11.6 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +2.3 % per year. As of Nov 5, 2026.
What discount rate (WACC) does the fair value of 014440 use?
Our models discount Youngbo Chem at 11.6 %: a base by market capitalisation (micro), damped by beta 0.41, country premium for South Korea. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Youngbo Chem that is +3.1 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (11.6 %) and the same formula as our fair value.
How much growth has Youngbo Chem (014440) delivered so far?
Over the past 5 years revenue at Youngbo Chem grew +2.3 % a year. The price currently implies free-cash-flow growth of +3.1 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Youngbo Chem (014440) growing?
The median revenue growth in the sector is +9.8 % a year. That is the yardstick for the growth priced into Youngbo Chem (+3.1 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Youngbo Chem (014440)?
The free-cash-flow yield on the price is 8.60 %: that much free cash flow Youngbo Chem produces per unit of market value. When it exceeds the discount rate of our models (11.6 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Youngbo Chem (014440)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Youngbo Chem it is 4,401 KRW per share (as of Nov 5, 2026), against a price of 4,660 KRW. It is the blended result of 24 valuation models in 8 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is Youngbo Chem stock overvalued or undervalued in 2026?
As of Nov 5, 2026, 014440 trades above its calculated fair value: price 4,660 KRW, fair value 4,401 KRW, a gap of about −6% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 014440?
No. The price is what the market pays today (4,660 KRW); the fair value is what the company's own numbers justify (4,401 KRW). For Youngbo Chem the two are 258.53 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is Youngbo Chem worth?
The market values Youngbo Chem at about 90.9B KRW (market capitalisation, as of Nov 5, 2026). Per share that is 4,660 KRW; our models calculate a fair value of 4,401 KRW per share.
What do the bullish and bearish scenarios say about 014440?
Our models span a range for Youngbo Chem: cautious scenario 3,916 KRW, base 4,401 KRW, optimistic 5,503 KRW per share (as of Nov 5, 2026, price 4,660 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 014440?
Youngbo Chem trades at a price-to-earnings ratio of 4.9 (as of Nov 5, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 4,401 KRW is built from several models across several years. Median P/E at fiscal year-end, 10 fiscal years (2016 to 2025), reported earnings: 12.0. Other multiples: P/B 0.5, P/S 0.7, EV/EBITDA 3.0.
How solid is the balance sheet of Youngbo Chem (014440)?
Balance-sheet figures for Youngbo Chem (as of Nov 5, 2026): return on equity 9.7%, debt of 0.01 per unit of equity. They feed the Quality Score of 59/100, which measures business quality independently of the share price.
How far is 014440 from its 52-week high?
Youngbo Chem trades at 4,660 KRW, about 7% below its 52-week high of 5,020 KRW and 12% above the low of 4,151 KRW (as of Nov 9, 2026). Distance from the high says nothing about value: that is what the fair value of 4,401 KRW is for.
Which stocks are comparable to Youngbo Chem?
From the same area (Basic Materials) we also value BASF SE, Saudi Basic Industries Corporation, Dow Inc, Ningxia Baofeng Energy Group, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Youngbo Chem stock attractive at the current price?
The data as of Nov 5, 2026: price 4,660 KRW, calculated fair value 4,401 KRW (−6%), Quality Score 59/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 014440 calculated?
We run Youngbo Chem through 24 models from 8 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of 4,401 KRW builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Youngbo Chem itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Youngbo Chem (014440)?
The closing price on Nov 9, 2026 was 4,660 KRW. Our model-based fair value is 4,401 KRW, about 6% lower (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Youngbo Chem right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. The price sits in the lower half of our model range, the side with the larger margin of safety. The data supports the verdict: every model runs on fully documented inputs.
Key figures of Youngbo Chem
How large is the market capitalisation of Youngbo Chem (014440)?
The market capitalisation of Youngbo Chem is 90.9B KRW (≈ $67.2M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Youngbo Chem (014440)?
The price-to-sales ratio of Youngbo Chem is 0.73 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Youngbo Chem (014440)?
Earnings per share at Youngbo Chem are 938.01 KRW (price ÷ EPS = P/E 4.9). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Youngbo Chem (014440)?
The dividend yield of Youngbo Chem is 7.5% (payout 37.3%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Youngbo Chem (014440)?
The net margin of Youngbo Chem is 14.6% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Youngbo Chem (014440)?
The return on equity (ROE) of Youngbo Chem is 9.7% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Youngbo Chem (014440)?
On an EBIT basis the return on assets of Youngbo Chem is 5.7% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Youngbo Chem (014440)?
The operating margin of Youngbo Chem is 15.9% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Youngbo Chem (014440)?
Revenue at Youngbo Chem is growing +11.4% versus a year earlier (3y avg +13.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Youngbo Chem (014440)?
Earnings per share at Youngbo Chem are growing +70.6% versus a year earlier. How much earnings per share grew versus a year earlier.
Free · no account needed
Watch Youngbo Chem in the live analysis
One click puts Youngbo Chem on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Broad data
Nov 5, 2026